Angiomyolipoma epidemiology and demographics

Revision as of 11:55, 6 November 2019 by Gunnam (talk | contribs) (→‎Epidemiology and Demographics)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma epidemiology and demographics

CDC on Angiomyolipoma epidemiology and demographics

Angiomyolipoma epidemiology and demographics in the news

Blogs on Angiomyolipoma epidemiology and demographics

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Faizan Sheraz, M.D. [3], Rekha, M.D.

Overview

The incidence of angiomyolipoma is approximately 30 per 100,000 individuals worldwide. Females are more commonly affected with angiomyolipoma than males. Angiomyolipoma commonly affects individuals older than 40 years of age.

Epidemiology and Demographics

Prevalence

Incidence

Gender

  • Females are more commonly affected with angiomyolipoma than males. The female to male ratio is approximately 4 to 1.

Age

References

  1. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
  2. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
  3. Bissler JJ, Kingswood JC (2004). "Renal angiomyolipomata". Kidney Int. 66 (3): 924–34. doi:10.1111/j.1523-1755.2004.00838.x. PMID 15327383.
  4. Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD (2010). "Trends of presentation and clinical outcome of treated renal angiomyolipoma". Yonsei Med J. 51 (5): 728–34. doi:10.3349/ymj.2010.51.5.728. PMC 2908871. PMID 20635448.

Template:WikiDoc Sources